| NCT Number | NCT04919980 |
| Lead Sponsor | Edwards Lifesciences |
| Conditions | Mitral Valve Regurgitation (Degenerative or Functional) |
| Enrollment | 65 participants |
| Start Date | 2022-09-01 |
| Primary Completion | 2026-07-01 (estimated) |
| Study Completion | 2031-07-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-28 |